Chapter 11: Co-Occurring Disorders and Integrated Treatment

Substance use disorders rarely occur in isolation. For many people, a diagnosis of alcohol use disorder, opioid use disorder, or any other substance use disorder coexists with at least one other mental health condition. The relationship between the two is bidirectional and complex. Substances may be used to self-medicate symptoms of depression, anxiety, or trauma. Substance use itself may precipitate or worsen psychiatric symptoms. And the neurological effects of prolonged use can produce emotional and behavioral patterns that closely resemble independent mental disorders. Understanding how to recognize, assess, and address these co-occurring conditions is one of the most clinically significant competencies in contemporary substance use practice.

The term co-occurring disorders (CODs) replaced earlier language, including dual diagnosis, to better reflect the clinical reality that a person may carry more than two diagnoses simultaneously. The current term indicates the presence of a substance use disorder alongside at least one other mental disorder, each of which can be diagnosed independently. The mental health conditions of concern are those defined in Section II of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR), excluding neurodevelopmental disorders such as intellectual disability or autism spectrum disorder, though those conditions can certainly coexist with substance use disorders and warrant clinical attention.

The evidence base is clear that co-occurring disorders are the norm rather than the exception in substance use treatment. Chapter 9 addressed the importance of screening for co-occurring conditions as part of comprehensive assessment. This chapter moves from identification to response, examining prevalence, the most common conditions, the diagnostic challenges involved, and the integrated treatment model that research consistently supports.

These figures represent a substantial increase from earlier estimates and emphasize why co-occurring disorders can no longer be treated as a subspecialty concern. They are the central clinical reality of substance use practice. The treatment gap is particularly important to note. When many people with both a mental health condition and a substance use disorder receive care for only one condition, or none at all (Substance Abuse and Mental Health Services Administration, 2026), the system is functionally failing many of the people who need it.

One of the fundamental challenges in working with co-occurring disorders is assessment. The symptoms of substance use disorders and many mental health conditions overlap in ways that make clean diagnosis difficult, particularly during early treatment. A person withdrawing from alcohol may present with severe anxiety, depression, and sleep disruption. A person recovering from stimulant use may exhibit paranoid thinking or flattened affect. In both cases, the question is whether the observed symptoms reflect the substance use itself, a co-occurring mental disorder, or both.

Two brief scenarios show why this matters. A client entering detoxification reports difficulty sleeping, poor appetite, and depression. Are these withdrawal symptoms or a depressive disorder? A client with a history of childhood sexual abuse enters treatment and initially appears to be doing well. Should the treating clinician probe for PTSD even if the client denies current distress? SAMHSA (2020) is direct about the answer: treatment of the substance use disorder and an abstinent period of weeks or months may be required before an independent co-occurring mental disorder can be diagnosed with confidence. A comprehensive psychosocial history, careful symptom tracking across the stabilization period, and observation during sustained sobriety are what make that judgment possible.

A central diagnostic principle is that symptoms of a mental disorder that appear only during active substance use or withdrawal must be distinguished from symptoms that were present before substance use began, persist beyond the acute detoxification period, or return after a substantial period of sobriety. A thorough intake assessment should ask about the chronology of symptoms: which came first, what changed with use, and what remained constant regardless of substance status. This history is not always easy to obtain accurately, particularly when clients have been using since adolescence and cannot reliably recall a time before substance use.

Several patterns complicate the diagnostic picture in specific ways. Antisocial personality disorder presents a particular challenge because many behaviors associated with active use, such as rule-breaking, dishonesty, impulsivity, and disregard for others, directly mirror the diagnostic criteria. The key distinguishing feature is behavioral history before age 15, before the onset of significant substance use, and behavior during sustained sobriety. A person whose problematic behavior disappears with recovery is unlikely to have antisocial personality disorder. A person who continues to cause harm to others while sober is demonstrating that the disorder exists independent of substance use.

PTSD warrants particular attention because its relationship to substance use is both common and clinically important. Studies consistently find high rates of PTSD among women in treatment, veterans, and justice-involved individuals. The critical clinical risk is that early recovery removes the primary coping mechanism, substance use, without providing replacement tools. When PTSD symptoms intensify in early sobriety, as they frequently do, the risk of relapse is elevated. Preparing clients for this possibility and providing trauma-informed support before symptoms emerge is more effective than responding after a crisis occurs.

The evidence base for treating co-occurring disorders is clear: integrated treatment, which addresses both the substance use disorder and the mental health condition simultaneously within a unified clinical framework, produces significantly better outcomes than treating each condition separately or sequentially. The older assumption that substance use must be fully addressed before mental health treatment can begin has been consistently contradicted by research. Untreated co-occurring conditions are among the most reliable predictors of relapse, and sequential treatment leaves the person managing two active conditions with only half the support they need.

The integrated treatment approach is formalized in the Substance Abuse and Mental Health Services Administration’s Integrated Treatment for Co-Occurring Disorders Evidence-Based Practices toolkit. Its seven core practice principles provide a useful framework for understanding what integrated care looks like in practice.

Seven Practice Principles of Integrated Treatment

1. Integration. Mental health and substance use treatment are organized and delivered as a unified service rather than parallel systems that the client must navigate independently.
2. Specialist training. Practitioners who provide integrated treatment are trained to address both substance use disorders and serious mental illness. They understand how conditions interact and how to adapt evidence-based approaches for this population.
3. Stage-based treatment. Integrated services are matched to the client’s stage of treatment, whether engagement, persuasion, active treatment, or relapse prevention, recognizing that different stages require different clinical emphasis and different levels of readiness for intervention.
4. Motivational approaches. Motivational interviewing (Chapter 10) is used throughout, with particular importance during the persuasion stage when clients may be ambivalent about treatment for one or both conditions.
5. Cognitive-behavioral substance use counseling. CBT-based approaches are used in the active treatment and relapse prevention stages, addressing the thoughts, behaviors, and coping patterns relevant to both the substance use and the co-occurring condition.
6. Multiple service formats. Integrated treatment is delivered across individual, group, peer support, and family modalities, recognizing that different clients and different stages benefit from different contexts.
7. Integrated medication services. Medication for both conditions is coordinated within the same treatment framework rather than managed by separate providers operating independently.

The capacity to deliver integrated treatment remains a significant challenge. Structural barriers have slowed the expansion of integrated programs, including separate funding streams for mental health and substance use treatment, distinct regulatory environments, and workforce preparation gaps (SAMHSA, 2020). Many substance use treatment facilities are not staffed or licensed to diagnose and treat mental disorders. Many mental health agencies lack the expertise to address substance use disorders effectively. The result is a system that requires integration but is organized in ways that make integration difficult.

For practitioners who do not work in formally integrated settings, the principles still apply. A generalist practitioner can maintain a shared clinical perspective, coordinate with providers across systems, monitor for co-occurring symptoms, apply motivational and cognitive-behavioral approaches, and advocate for clients who are being treated in fragmented systems. Integrated care is not only a program model. It is a clinical orientation.

Substance use disorders do not affect all populations in the same way. Age, gender, sexual orientation and gender identity, involvement with the criminal legal system, and disability each shape the experience of substance use, the barriers to treatment, the most effective interventions, and the likelihood of sustained recovery. This section examines populations whose needs are frequently underserved by standard treatment models and whose characteristics require deliberate clinical attention.

Adolescents

Adolescents present a different clinical profile than adults, and many treatment models developed for adults translate poorly to younger clients. Adolescents are less likely to have experienced the sustained consequences of substance use, such as job loss, family dissolution, and serious legal consequences, that motivate many adults to engage in treatment. They may be skeptical of models that ask them to identify as having a lifelong disease. They are developmentally oriented toward peer acceptance and may resist treatment recommendations that require separating from using peer groups.

Evidence-based approaches for adolescents include functional family therapy, multidimensional family therapy, and group cognitive-behavioral therapy (Waldron & Turner, 2008). Family involvement is consistently identified as a critical factor. Schools and juvenile justice systems are often the first systems to identify adolescent substance use concerns and can serve as important entry points for earlier intervention.

Older Adults

Substance use disorders among older adults are frequently underidentified. Health care providers and family members may attribute symptoms, such as falls, cognitive difficulties, and mood changes, to aging rather than to substance use. The physiology of aging also changes how substances affect the body. Older adults have slower metabolism and a smaller volume of distribution, which means quantities that were manageable in earlier life may now produce significant impairment or health consequences. The National Institute on Alcohol Abuse and Alcoholism recommends that adults over 65 who are healthy and do not take medications limit alcohol use to no more than three standard drinks on any given day and no more than seven per week, guidelines more restrictive than those for younger men (National Institute on Alcohol Abuse and Alcoholism, n.d.).

The clinical presentation of older adults often includes grief, bereavement, retirement-related identity loss, physical pain from chronic illness, social isolation, and loneliness. Age-specific treatment programming shows better outcomes than placing older adults in standard programs not designed for their circumstances. These considerations align directly with the person-centered assessment principles developed in Chapter 9.

Women

Although substance use disorders are diagnosed at lower rates among women than men, women face a distinct set of barriers to treatment and a different clinical trajectory. Greenfield et al. (2007) identified pregnancy, fear of losing custody, lack of child care, financial dependence, high rates of co-occurring disorders, and histories of physical or sexual abuse as barriers specific to women. Between 30 and 59 percent of women in substance use treatment carry a diagnosis of PTSD, most often stemming from repetitive childhood physical or sexual abuse. The rate among men in treatment is roughly two to three times lower, and their trauma histories more often involve combat or crime victimization (Najavits et al., 1997). This intersection of trauma and substance use is not incidental. It is a defining feature of the clinical presentation for a significant proportion of women in treatment.

Treatment that addresses trauma alongside substance use, incorporates peer support, provides child care or family services, and creates environments safe from gender-based harm produces better outcomes for women. The Seeking Safety model, introduced in Chapter 10, was designed specifically for this population and addresses PTSD and substance use simultaneously without requiring trauma processing before stabilization.

LGBTQ+ Individuals

Research consistently documents elevated rates of substance use disorders among lesbian, gay, bisexual, transgender, and queer individuals compared to heterosexual and cisgender populations (Cochran et al., 2004; Hughes et al., 2006). Minority stress, the chronic stress produced by stigma, discrimination, concealment, and internalized heterosexism, is the primary explanatory framework for this disparity. Substance use may function as a coping response to minority stressors that are themselves structural rather than individual.

Access to treatment does not by itself close these gaps. In a national analysis of adults with substance use disorder, sexual minority adults used mental health treatment at higher rates than their heterosexual peers yet were more than twice as likely to report unmet mental health need, a disparity that persisted after accounting for demographics, family income, psychological distress, and co-occurring mental illness (Coble et al., 2026). The problem this points to is not simply who enters treatment but what happens once they are there. Stigma operates inside care settings, not only outside them: when treatment asks clients to translate their lives for providers who do not recognize their stressors, contact with services does not guarantee that the care received meets their needs. Treatment environments that do not affirm LGBTQ+ identities are not merely unwelcoming. They can leave clients formally in care while the concerns that brought them there, including the relationship between their identity and their substance use and the effects of minority stress on recovery, go unaddressed.

Justice-Involved Individuals

The intersection of substance use disorders and criminal legal involvement is extensive. As Chapter 6 established, the majority of people incarcerated in the United States have significant substance use histories. The consequences of inadequate or absent treatment for this population extend well beyond the individual. They include ongoing public health costs, community destabilization, and cycles of incarceration that serve neither justice nor recovery.

Drug courts and diversion programs represent an evidence-based response. When substance use is treated as a health concern rather than exclusively a criminal justice problem, and when legal supervision is paired with access to treatment, housing, transportation, employment support, and community-based recovery resources, outcomes improve significantly. The critical factor is that supervision without services does not produce recovery. Legal leverage is most effective when it opens doors to comprehensive care rather than simply monitoring compliance.

For practitioners in clinical settings, justice involvement shapes the treatment context in important ways. Clients may be in treatment under court mandate, experiencing trauma from incarceration or supervision, managing the practical barriers of reentry, such as lack of identification, housing instability, and limited employment options, and dealing with stigma that compounds what they already carry from the substance use disorder itself.

People with Disabilities

People with disabilities can face heightened risk for substance use and substance use disorders, and they encounter significant barriers that limit access to appropriate treatment (SAMHSA, 2011). About one in four adults in the United States lives with a disability (Centers for Disease Control and Prevention, 2024), a category that spans physical, sensory, cognitive, intellectual, and psychiatric conditions. The reasons for elevated risk include chronic pain, social isolation, unemployment, and the stress of navigating a world that is often not built for them. Many also live with co-occurring mental health conditions, which compounds both the risk and the difficulty of getting appropriate care.

The barriers to treatment fall into a few recognizable groups. Physical and architectural barriers, such as the absence of ramps, elevators, or accessible restrooms, can make a facility unusable for someone with a mobility or sensory disability. Communication barriers arise when programs lack interpreters, materials in accessible formats, or staff trained to work with clients who process information differently. Attitudinal barriers and stigma lead some providers to assume a person cannot benefit from treatment, or to overlook substance use entirely because they attribute every symptom to the disability. Discriminatory policies and the simple lack of programs designed with disability in mind round out the picture (SAMHSA, 2011).

A particular challenge involves disabilities that are not visible. Learning disabilities, cognitive impairments, traumatic brain injury, and chronic health conditions may not be obvious during an intake, and clients with these conditions often receive standard services that do not fit how they learn or what they need. Treatment models built on abstract concepts can be especially hard to apply. A person with a cognitive or intellectual disability may struggle with material that assumes a particular reading level or comfort with abstraction, which means the same group session that works for one client may exclude another.

The Americans with Disabilities Act of 1990 (ADA) established the legal obligation to remove or accommodate these barriers, but legal access and meaningful access are not the same thing. Effective practice means assessing a program from the perspective of a client with a disability, asking whether the building, the materials, the communication, and the clinical approach actually work for that person. The goal is not a separate track for people with disabilities, but care that is accessible and adaptable from the start.

The preceding sections have established what co-occurring disorders are, why they are common, how to approach assessment, what integrated treatment involves, and how population characteristics shape the clinical picture. The populations examined in the previous section are some of those most often underserved, but they are not the only ones, and no person belongs to just one of them. A client may be an older adult, a veteran, a parent, and a person with a disability all at once. The point of naming specific populations is not to build a checklist or a separate track for each group. It is to make clear that a single, standard model of treatment does not fit everyone, and that effective care begins with the particular person rather than a generic protocol. This section focuses on the connecting thread: all of it depends on person-centered, ethically grounded practice.

Person-Centered Care with Co-Occurring Disorders

Chapter 9 established that assessment is not a technical task performed on a person. It is a relational process conducted with them. The same principle governs treatment. People with co-occurring disorders are not diagnostic categories. They are individuals whose conditions are part of a larger life. Effective treatment requires understanding that life. A person with PTSD and alcohol use disorder who is also a parent, a survivor of domestic violence, and a recent job loss is not presenting with two conditions. They are presenting as a person navigating enormous complexity. Clinical planning that does not account for the full context will not be sufficient.

Recovery Is Possible

One of the most important things a practitioner can communicate, and genuinely believe, is that recovery from co-occurring disorders is achievable. The presence of multiple diagnoses does not reduce hope. It clarifies the scope of care needed. People with serious mental illness and substance use disorders recover. People with PTSD and alcohol use disorder find stability. People who have been through the criminal legal system, who have experienced profound trauma, who have lived through years of untreated symptoms, they recover. The evidence base for integrated treatment exists precisely because researchers have documented that recovery is happening, and because it is more likely when care is comprehensive (Substance Abuse and Mental Health Services Administration, 2009).

Recovery is not only a destination. It is a process that looks different for every person. For practitioners working with co-occurring disorders, that reality requires flexibility, sustained engagement, and a commitment to the whole person, not just the diagnosis.

Co-occurring disorders. The presence of a substance use disorder and at least one mental health condition in the same person, also once called dual diagnosis.

Diagnostic challenge. The difficulty of telling apart substance-induced symptoms from an independent mental health condition, since the two often overlap.

Integrated treatment. An approach that addresses the substance use disorder and the mental health condition at the same time, within a single, unified clinical framework.

Minority stress. The chronic stress produced by stigma, discrimination, concealment, and internalized prejudice, which helps explain elevated substance use risk among LGBTQ+ people.

Person-centered practice. A relational approach in which assessment and treatment are conducted with the client rather than performed on them, attending to the whole person.

Recovery. An ongoing, individually defined process of change through which a person improves health and wellness and works toward their own goals, possible even after years of untreated symptoms.

Stages of treatment. The sequence of engagement, persuasion, active treatment, and relapse prevention to which integrated care is matched.

Substance-induced symptoms. Symptoms that result from intoxication or withdrawal and may resolve with sustained abstinence, as distinct from an independent mental health disorder.

Centers for Disease Control and Prevention. (2024). Disability impacts all of us [Infographic]. U.S. Department of Health and Human Services. https://www.cdc.gov/disability-and-health/articles-documents/disability-impacts-all-of-us-infographic.html

Coble, S., Vaughn, M. G., & Chen, J.-H. (2026). Access without adequacy: Depression, suicidality, and unmet substance use treatment need among sexual minority adults [Manuscript submitted for publication]. School of Social Work, Saint Louis University.

Cochran, S. D., Ackerman, D., Mays, V. M., & Ross, M. W. (2004). Prevalence of non-medical drug use and dependence among homosexually active men and women in the US population. Addiction, 99(8), 989–998.

Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K., Lincoln, M., Hien, D., & Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence, 86(1), 1–21.

Hughes, T. L., Wilsnack, S. C., Szalacha, L. A., Johnson, T., Bostwick, W. B., Seymour, R., Aranda, F., Benson, P., & Kinnison, K. E. (2006). Age and racial/ethnic differences in drinking and drinking-related problems in a community sample of lesbians. Journal of Studies on Alcohol, 67(4), 579–590.

Najavits, L. M., Weiss, R. D., & Shaw, S. R. (1997). The link between substance abuse and posttraumatic stress disorder in women: A research review. American Journal on Addictions, 6(4), 273–283.

National Institute on Alcohol Abuse and Alcoholism. (n.d.). Older adults. U.S. Department of Health and Human Services. Retrieved July 23, 2026, from https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics-z/alcohol-facts-and-statistics/alcohol-and-older-adults-ages-65

Substance Abuse and Mental Health Services Administration. (2009). Integrated treatment for co-occurring disorders: The evidence (DHHS Publication No. SMA-08-4366). U.S. Department of Health and Human Services. https://library.samhsa.gov/product/integrated-treatment-co-occurring-disorders-evidence-based-practices-ebp-kit/sma08-4366

Substance Abuse and Mental Health Services Administration. (2011). Substance use disorders in people with physical and sensory disabilities (In Brief, Vol. 6, Issue 1). U.S. Department of Health and Human Services.

Substance Abuse and Mental Health Services Administration. (2020). Substance use disorder treatment for people with co-occurring disorders (Treatment Improvement Protocol [TIP] Series, No. 42; SAMHSA Publication No. PEP20-02-01-004). https://library.samhsa.gov/product/tip-42-substance-use-treatment-persons-co-occurring-disorders/pep20-02-01-004

Substance Abuse and Mental Health Services Administration. (2026). Key substance use and mental health indicators in the United States: Results from the 2025 National Survey on Drug Use and Health (HHS Publication No. PEP26-07-010, NSDUH Series H-61). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases

Waldron, H. B., & Turner, C. W. (2008). Evidence-based psychosocial treatments for adolescent substance abuse. Journal of Clinical Child & Adolescent Psychology, 37(1), 238–261.